
Angela Hong
@angelahong
Radiation Oncologist, Cancer Researcher, Views are my own
ID: 35186917
25-04-2009 10:18:51
327 Tweet
245 Followers
189 Following

Just in time for #CTOS2024: Thrilled to share SU2C-SARC032 (NCT03092323), a randomized trial of pembrolizumab in Stage 3 extremity soft tissue sarcoma, now published The Lancet! authors.elsevier.com/a/1k5JbV-4XOupH 1/13 SARC Stand Up To Cancer CTOS Radiation Medicine Program Princess Margaret Cancer Centre University Health Network Radiation Oncology

Princess Margaret Cancer Centre SARC Hussein Tawbi, MD, PhD Yvonne Mowery UPMC Duke Cancer Richard Riedel With funding from a Stand Up To Cancer Catalyst Grant with support from Merck and a Merck Investigator Studies Program (MISP) Grant, we enrolled patients at 20 academic centers in Australia, Canada, Italy, and USA. Angela Hong accrued 25% of all patients in Sydney! 7/13

Thrilled to announce that the SU2C-SARC032 clinical trial has been published in The Lancet! A huge thank you to everyone who contributed to this important study—your hard work and dedication are truly appreciated! Stand Up To Cancer David Kirsch, MD, PhD #sarcoma #SARCTrials




The Australia and New Zealand Sarcoma Association #sarcoma journal club is retuning for its 5th year. The New Zealand team will host on the first on the 12th Feb. Join this virtually to hear the latest in sarcoma research .

It was a momentous time celebrating AusoftheYearAwards 2025 with my daughters (one watching proudly from the USA!), my rock of a husband, and my wise brilliant mum. As I welcome our inspiring new awardees, I reflect on an incredible 2024: pioneering melanoma research that transformed







A/Prof Sarat Chander paper on automated planning for Lattice Radiation Therapy has been named one of the top 10% most-viewed papers of 2023 by Medical Physics. Part-funded by ANZSA, this work paves the way for more efficient, consistent treatment of complex tumours.


The Australia and New Zealand Sarcoma Association scientific advisory committee meeting was an exciting and fruitful day to discuss ongoing trials, database upgrade and new #research ideas. Shout out to the consumers who provided insightful feedback. David Gyorki Fiona Maclean




We’re pleased to announce that Winship Cancer Institute of Emory University in the US, is the second international site to join the ReLaPSe study - a prospective study evaluating standard treatment options for patients who’ve had a recurrence of a resected #retroperitoneal #liposarcoma.

Next Thursday! Join us for our second #sarcomaawarenessmonth Webinar in collaboration with VCCC Alliance Register here: vcccalliance.org.au/news-and-event…


Today our wonderful Deputy Chair, Professor Angela Hong, lead her GenesisCare Plank-a-thon team in Sydney for sarcoma research! To sign up or show your support, please visit sarcomaplankathon.com #sarcomaawareness #research #teamspirit
